Viewing nowCombinationSitagliptin and Metformin Duo Tablet 50/1000 mg
Sitagliptin Hydrochloride Hydrate 56.69mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Dae Hwa Pharmaceutical Co., Ltd.

MFDS item code 202300760 · Approved 2023.03.06 · Insurance code 645605870
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps improve blood sugar control when used alongside diet and exercise for patients with type 2 diabetes. The combination of sitagliptin and metformin aids in stabilizing blood sugar levels, providing positive effects on diabetes management. This medication is used as an adjunct when diet and exercise alone are insufficient to improve blood sugar control.
In antidiabetic therapy, the dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: sitagliptin 100 mg and metformin 2000 mg. This drug is generally taken twice daily with food. To reduce gastrointestinal adverse reactions caused by metformin, the dose should be increased gradually. The initial dose of this drug should be determined according to the patient's current treatment regimen. 1. Patients not currently receiving metformin: For patients who have not previously received drug therapy for diabetes and whose blood glucose is not adequately controlled with monotherapy, or whose blood glucose cannot be adequately controlled with sitagliptin monotherapy, the initial dose is 1 tablet of this drug 50/500 mg twice daily. The dose may be increased to 1 tablet of this drug 50/1000 mg twice daily. Patients with renal impairment who are receiving a reduced dose of sitagliptin should not be switched to this drug. 2. Patients receiving metformin: - For patients whose blood glucose is not adequately controlled with metformin monotherapy, the recommended initial dose of this drug is sitagliptin 50 mg twice daily (total daily dose 100 mg) and the patient's current metformin dose. - Patients switching from concomitant sitagliptin and metformin therapy to this drug may start at their current doses of sitagliptin and metformin. 3. Patients whose blood glucose is not adequately controlled with concomitant metformin and sulfonylurea, metformin and insulin, or metformin and thiazolidinedione therapy: The initial dose of this drug is sitagliptin 50 mg twice daily (total daily dose 100 mg), and the initial dose of metformin should take the patient's blood glucose level and current dose into consideration. To reduce gastrointestinal adverse reactions caused by metformin, the dose should be increased gradually. When this drug is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia caused by the sulfonylurea or insulin. No studies have been conducted to evaluate the safety and efficacy of switching patients previously treated with another oral antihyperglycemic agent to this drug. Any change in treatment for type 2 diabetes may alter blood glucose control; therefore, caution should be exercised and appropriate monitoring should be performed. Patients with renal impairment This drug may be used, with the following dose adjustments, in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] ≥ 45 and < 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and < 60 mL/min/1.73m2), who do not have other conditions that may increase the risk of lactic acidosis. Treatment should not be initiated with this drug because the starting dose of metformin is 500 mg or 850 mg once daily. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 mL/min or eGFR < 45 mL/min/1.73m2, this drug should be discontinued immediately.
This medication contains two components, each with specific precautions to consider. First, one of its components can rarely cause severe allergic reactions. Such reactions may appear within 3 months after starting the medication, and if symptoms like skin rashes or breathing difficulties occur, usage should be stopped immediately, and a doctor should be consulted. Second, this medication can induce pancreatitis, an inflammation of the pancreas. Symptoms such as abdominal pain, vomiting, or fever must be reported to a doctor promptly. Third, the other component should not be administered to patients with renal impairment, severe infections, or dehydration. Additionally, patients with acute myocardial infarction, heart failure, or those who are pregnant or breastfeeding should not take this medication. Fourth, this medication may cause lactic acidosis, a rare but life-threatening metabolic complication, so patients with kidney or liver issues must consult their doctor before taking it. Fifth, during treatment, regular kidney function and blood tests should be conducted, and vitamin B12 levels should be periodically checked as deficiencies may occur. Sixth, this medication may cause hypoglycemia, so it is essential to monitor blood sugar levels regularly, especially when taken with other hypoglycemic drugs or insulin, and to take prompt action if hypoglycemic symptoms arise. Seventh, this medication should be temporarily discontinued before and after surgery or prior to tests using iodinated contrast agents, and should only be resumed once kidney function is confirmed to be normal. Eighth, alcohol consumption may increase the risk of side effects related to this medication, so it is advisable to avoid drinking while on it. Ninth, elderly patients or those with poor nutritional status are at higher risk for hypoglycemia and lactic acidosis, thereby requiring extra caution and regular health check-ups. Lastly, if unusual symptoms or discomfort occurs during treatment with this medication, it is crucial to consult healthcare professionals for appropriate measures.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air penetration and should be kept at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's efficacy and safety.
Brownish-red oval film-coated tablet
Bottle - 100 tablets/bottle, Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 56.69mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Dae Hwa Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.